DIFFERENTIALLY REGULATED PRODUCTION OF PLATELET-DERIVED GROWTH-FACTOR AND OF TRANSFORMING GROWTH FACTOR-BETA BY A HUMAN TERATOCARCINOMA CELL-LINE

被引:17
作者
WEIMA, SM
VANROOIJEN, MA
MUMMERY, CL
FEIJEN, A
KRUIJER, W
DELAAT, SW
VANZOELEN, EJJ
机构
关键词
D O I
10.1111/j.1432-0436.1988.tb00214.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:203 / 210
页数:8
相关论文
共 53 条
[31]   CELL-CYCLE ANALYSIS DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF A HUMAN EMBRYONAL CARCINOMA-DERIVED CELL-LINE [J].
MUMMERY, CL ;
VANROOIJEN, MA ;
VANDENBRINK, SE ;
DELAAT, SW .
CELL DIFFERENTIATION, 1987, 20 (2-3) :153-160
[32]   PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-II (MSA) BY ENDODERM-LIKE CELLS DERIVED FROM EMBRYONAL CARCINOMA-CELLS - POSSIBLE MEDIATOR OF EMBRYONIC-CELL GROWTH [J].
NAGARAJAN, L ;
ANDERSON, WB ;
NISSLEY, SP ;
RECHLER, MM ;
JETTEN, AM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 124 (02) :199-206
[33]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF MASKING PROTEIN FOR BETA-TYPE TRANSFORMING GROWTH-FACTOR FROM RAT PLATELETS [J].
NAKAMURA, T ;
KITAZAWA, T ;
ICHIHARA, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (01) :176-184
[34]   A GLIOMA-DERIVED ANALOG TO PLATELET-DERIVED GROWTH-FACTOR - DEMONSTRATION OF RECEPTOR COMPETING ACTIVITY AND IMMUNOLOGICAL CROSSREACTIVITY [J].
NISTER, M ;
HELDIN, CH ;
WASTESON, A ;
WESTERMARK, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (03) :926-930
[35]   EFFECT OF CHOLESTEROL AND GROWTH-FACTORS ON THE PROLIFERATION OF CULTURED HUMAN-SKIN FIBROBLASTS [J].
OSTLUND, RE ;
YANG, JW .
EXPERIMENTAL CELL RESEARCH, 1985, 161 (02) :509-516
[36]  
PIRCHER R, 1984, CANCER RES, V44, P5538
[37]   PRODUCTION OF PDGF-LIKE GROWTH-FACTORS BY EMBRYONAL CARCINOMA-CELLS AND BINDING OF PDGF TO THEIR ENDODERM-LIKE DIFFERENTIATED CELLS [J].
RIZZINO, A ;
BOWENPOPE, DF .
DEVELOPMENTAL BIOLOGY, 1985, 110 (01) :15-22
[38]  
RIZZINO A, 1986, CANCER RES, V46, P2816
[39]   LACK OF CORRELATION BETWEEN LOSS OF ANCHORAGE-INDEPENDENT GROWTH AND LEVELS OF TRANSFORMATION-SPECIFIC P53 PROTEIN IN RETINOIC ACID-TREATED F9 EMBRYONAL CARCINOMA-CELLS [J].
RODRIGUES, M ;
BALICKI, D ;
NEWROCK, KM ;
MUKHERJEE, BB .
EXPERIMENTAL CELL RESEARCH, 1985, 156 (01) :22-30
[40]   MONOCLONAL-ANTIBODY TO MURINE EMBRYOS DEFINES A STAGE-SPECIFIC EMBRYONIC ANTIGEN EXPRESSED ON MOUSE EMBRYOS AND HUMAN TERATOCARCINOMA CELLS [J].
SHEVINSKY, LH ;
KNOWLES, BB ;
DAMJANOV, I ;
SOLTER, D .
CELL, 1982, 30 (03) :697-705